Global Prednisolone Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Prednisolone Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Prednisolone market finds that the global Prednisolone market reached a value of USD 159.23 million in 2022. It’s expected that the market will achieve USD 252.53 million by 2028, exhibiting a CAGR of 7.99% during the forecast period.

New product development

In the pharmaceutical industry, the beginning of new products has always been one of the driving forces of the industry. The development of new drugs requires rigorous testing. During clinical trials, a large proportion of new drug candidates failed to enter the market. Although prednisolone currently has a wide range of applications, there are still some adverse reactions, and there are more unknown applications that can be explored. With the continuous development of medicine and the pharmaceutical industry, the understanding of various diseases will be deepened in the future. The continuous updating and upgrading of drugs is an inevitable law of the industry. The continuous research and development of new products will bring more opportunities to the prednisolone industry in the future.

Challenges of supply chain trade

The development of global economic integration and the development of digital information technology have caused more and more pharmaceutical companies to start global trade. Global networks and e-commerce connect pharmaceutical manufacturers with overseas markets to provide medicines to customers in a wider range of markets. But the actual implementation is not so simple. While pharmaceutical companies create a global market for their products, they must also comply with the requirements of regulatory agencies in different countries. At the same time, the composition of drugs is complex, and it takes time to apply for marketing licenses in different regions. In addition, the timing of the launch of drugs on the market is also very important. Product shortages may cause inconvenience and even danger, which will lead to counterfeit products entering the drug market. Cross-border trade requires excellent logistics and planning to reduce the pressure on the international supply and distribution chain. Pharmaceuticals such as prednisolone have huge opportunities in the international market, but the decentralized distribution and regulatory systems in supply chain trade will bring corresponding challenges to the industry.

Region Overview:

In global comparison, a significant portion of the revenue was generated in North America (34.08% in 2021).

Company Overview:

Sanofi is one of the major players operating in the Prednisolone market, holding a share of 15.11% in 2022.

Sanofi

Sanofi operates as a pharmaceutical company. The Company manufactures prescription pharmaceuticals and vaccines. Sanofi also develops cardiovascular, thrombosis, metabolic disorder, central nervous system, and oncology medicines and drugs.

Tianjin Pharmaceutical Holdings Co., Ltd.

Tianjin Pharmacy Holdings Co., Ltd. manufactures pharmaceuticals. The Company researches, produces, and distributes cold drugs, pediatric medicines, diabetes medicines, oncology drugs, and more.

Segmentation Overview:

Among different product types, Oral Solution segment is anticipated to contribute the largest market share in 2027.

Application Overview:

In the Prednisolone market, 22.33% of the total value was generated through the Rheumatoid Arthritis segment by application in 2021.

Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory disease. Unlike the wear and tear of osteoarthritis, rheumatoid arthritis affects the joint lining, causing painful swelling, which ultimately leads to bone erosion and joint deformities. Prednisolone can stimulate glucocorticoid receptors in cells, thereby inhibiting harmful cytokines, which can reduce inflammation and the pain and stiffness associated with it.

Bells Palsy

Bell's palsy is a disease that causes temporary weakness or paralysis of facial muscles. This happens when the nerves that control the facial muscles become inflamed, swollen, or compressed. Prednisolone has an effective anti-inflammatory effect, which can reduce facial nerve inflammation in patients with Bell's palsy, thereby improving symptoms.

Acute Lymphoblastic Leukemia

Acute lymphocytic leukemia (ALL) is a hemolymphoid line cancer characterized by the development of large numbers of immature lymphocytes. In the treatment of acute lymphoblastic leukemia, prednisolone can help destroy leukemia cells, making chemotherapy more effective.

Autoimmune Hepatitis

Autoimmune hepatitis is a disease in which the body's immune system attacks liver cells. This immune response can cause liver inflammation. The disease can be very serious, and if left untreated, it will worsen over time, leading to liver cirrhosis and/or liver failure. Glucocorticoids such as prednisone can control inflammation in the liver, thereby preventing further scarring.

Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease. In this disease, the body's immune system mistakenly attacks healthy tissues. Prednisone is the most commonly used steroid in systemic lupus erythematosus. Prednisone reduces the activity of the immune system by affecting the cell function of white blood cells in the blood, helping to slow down and prevent the process of inflammatory molecules in the body.

Vasculitis

Vasculitis is inflammation of blood vessels. This happens when the body's immune system mistakenly attacks blood vessels. Prednisone is usually used in combination with other immunosuppressive drugs to treat vasculitis.

Crohn's Disease

Crohn's disease is an inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract. Prednisolone is a steroid drug that can reduce the symptoms of Crohn's disease by reducing inflammation in the digestive system.

Key Companies in the global Prednisolone market covered in Chapter 3:

Mahima life Sciences
Sanofi
Symbiotec Pharma
Hunan Yuxin Pharmaceutical
Xianju Pharma
Henan Lihua Pharmaceutical
Wuhan DKY Technology
Tianjin Pharmaceutical Holdings Co., Ltd.
Shandong Taihua Bio &Tech

In Chapter 4 and Chapter 14.2, on the basis of types, the Prednisolone market from 2018 to 2029 is primarily split into:

Tablets
Oral Solution

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Prednisolone market from 2018 to 2029 covers:

Rheumatoid Arthritis
Bells Palsy
Acute Lymphoblastic Leukemia
Autoimmune Hepatitis
Systemic Lupus Erythematosus
Dermatomyositis
Vasculitis
Crohns Disease
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)